APP and proteostasis deficiencies: Alzheimer’s disease (AD) is a neurodegenerative disease initially defined by a proteinopathy associated with the accumulation of amyloid beta (Aβ) peptides that are produced through the sequential cleavage of the amyloid precursor protein (APP) by the β- and the γ-secretases [12].